Maximus/$MMS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Maximus

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Ticker

$MMS

Primary listing

NYSE

Industry

Professional Services

Employees

41,100

ISIN

US5779331041

Maximus Metrics

BasicAdvanced
$3.9B
14.01
$5.00
0.61
$1.20
1.71%

What the Analysts think about Maximus

Analyst ratings (Buy, Hold, Sell) for Maximus stock.

Bulls say / Bears say

Maximus reported adjusted earnings per share of $2.01 for the quarter ended March 31, 2025, surpassing analyst expectations of $1.38, indicating strong financial performance. (reuters.com)
Stifel raised its price target for Maximus from $105.00 to $110.00, maintaining a 'Buy' rating, reflecting confidence in the company's growth prospects. (investing.com)
Maximus increased its full-year earnings guidance following strong first-quarter results, indicating optimism about future performance. (stocktitan.net)
Maximus shares declined by 1.5% in the quarter ended March 31, 2025, and have lost 10.0% so far this year, indicating potential investor concerns. (reuters.com)
Insider selling activity, such as the sale of 14,500 shares by insider Ilene R. Baylinson, may signal a lack of confidence in the company's near-term prospects. (americanbankingnews.com)
Short interest in Maximus increased by 39.4% in February 2025, suggesting that more investors are betting against the stock. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

Maximus Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Maximus Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MMS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs